ARL-15896, a novel N-methyl-D-aspartate receptor ion channel antagonist: Neuroprotection against mitochondrial metabolic toxicity and regional pharmacology

Experimental Neurology

Volumn 137, Issue 1, 1996, Pages 66-72

  Greene, James G ^a   Porter, Richard H P ^a   Greenamyre, J Timothy ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA PHENYL 2 PYRIDINEETHANEAMINE; DIZOCILPINE; EXCITOTOXIN; LANICEMINE; MALONIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN INJURY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029671238     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0007     Document Type: Article

References (32)

1. BEAL, M. F., B. T. HYMAN, AND W. KOROSHETZ. 1993. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16: 125-131.
2. DAVOLIO, C., AND J. T. GREENAMYRE. 1995. Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acid. Neurosci. Lett. 192: 29-32.
3. DINGLEDINE, R., R. M. BOLAND, N. L. CHAMBERLIN, K. KAWASAKI, N. W. KLECKNER, S. F. TRAYNELIS, AND T. A. VERDOON. 1988. Amino acid receptors and uptake systems in the mammalian central nervous system. Crit. Rev. Neurobiol. 4: 1-96.
4. KIEBURTZ, K., M. MCDERMOTT, A. FEIGIN, P. COMO, D. ABWENDER, C. ZIMMERMAN, C. HICKEY, C. ORME, K. BORDWELL, J. SOTACK, C. DUNN, J. T. GREENAMYRE, AND I. SHOULSON. 1994. A controlled trial of the glutamate antagonist remacemide hydrochloride in Huntington's disease. Soc. Neurosci. Abstr. 248.
5. GREENAMYRE, J. T., R. V. ELLER, Z. ZHANG, A. OVADIA, R. KURLAN, AND D. M. GASH. 1994. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann. Neurol. 35: 655-661.
6. GREENE, J. G., R. H. P. PORTER, R. V. ELLER, AND J. T. GREENAMYRE. 1993. Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61: 1151-1154.
7. GREENE, J. G., AND J. T. GREENAMYRE. 1995. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64: 430-436.
8. HENSHAW, R., B. G. JENKINS, J. B. SCHULZ, R. J. FERRANTE, N. W. KOWALL, B. R. ROSEN, AND M. F. BEAL. 1994. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain. Res. 647: 161-166.
9. ISHII, T., K. MORIYOSHI, H. SUGIHARA, K. SAKURADA, H. KADOTANI, M. YOKOI, C. AKAZAWA, R. SHIGEMOTO, N. MIZUNO, M. MASU, AND S. NAKANISHI. 1993. Molecular characterization of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268: 2836-2843.
10. IVERSEN, L. L., G. W. WOODRUFF, J. A. KEMP, A. C. FOSTER, R. MCKERNAN, R. GILL, AND E. H. F. WONG. 1989. Noncompetitive NMDA antagonists as drugs. Pages 217-226 in J. C. Watkins and G. L. Collingridge, Eds. The NMDA Receptor. IRL Press, Oxford.
11. JOHNSON, J. W., AND P. ASCHER. 1987. Glycine potentiated the NMDA response in cultured mouse neurons. Nature 325: 529-533.
12. KEMP, J. A., A. C. FOSTER, AND E. H. F. WONG. 1987. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci. 10: 294-299.
13. KLECKNER, N., AND R. DINGLEDINE. 1988. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241: 835-837.
14. KORNHUBER, J., J. BARMANN, M. HÜBERS, K. RUSCHE, AND P. RIEDERER 1991. Effects of the 1-amino-adamantanes at the MK-801 binding site of the NMDA-receptor ion channel: A human postmortem brain study. Eur. J. Pharmacol. Mol. Pharmacol 206: 297-300.
15. KUTSUWADA, T., N. KASHIWABUCHI, H. MORI, K. SAKIMURA, E. KUSHIYA, K. ARAKI, H. MEGURA, H. MASAKI, T. KUMANISHI, M. ARAKAWA, AND M. MISHINA. 1992. Molecular diversity of the NMDA receptor channel. Nature 358: 36-41.
16. LAURIE, D. J., AND P. H. SEEBERG. 1994. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. [Mol. Pharmacol. Sect.] 268: 335-345.
17. MACDERMOTT, A. B., M. L. MAYER, G. L. WESTBROOK, S. J. SMITH, AND J. L. BARKER 1986. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321: 519-522.
18. MELDRUM, B. S. 1985. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68: 113-122.
19. MONYER, H., R. SPRENGAL, R. SCHOEPFER, A. HERB, M. HIGUCHI, H. LOMELI, N. BURNAHEV, B. SAKMANN, AND P. H. SEEBERG. 1992. Heteromeric NMDAreceptors: Molecular and functional distinction of subtypes. Science 256: 1217-1221.
20. MUNSUN, P. J., AND D. RODBARD. 1984. Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239.
21. NOWAK, L., P. BREGESTOVSKI, P. ASCHER, A. HERBET, AND A. PROCHIANTZ. 1984. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462-465.
22. PALMER, G. C., E. F. CREGAN, R. J. MURRAY, M. BALESTRA, A. S. HOWELL, C. L. CRAMER, T. J. HUDZIK, D. V. WIDZOWSKI, F. C. KAISER, D. SLOANE, R. K. RAY, J. T. GREENAMYRE, A. M. BUCHAN, AND D. XUE. 1994. Neuroprotective properties of FPL 15896AR, a novel uncompetitive NMDA receptor antagonist with additional sigma-1 properties. At New Strategies to Prevent Neural Damage from Ischemic Stroke, October 27-28, Cambridge, MA. [Abstract]
23. PALMER, G. C., R. J. MURRAY, T. C. M. WILSON, M. S. EISMAN, R. K. RAY, R. C. GRIFFITH, J. J. NAPIER, M. FEDORCHUK, M. L. STAGNITTO, AND G. E. GARSKE. 1992. Biological profile of the metabolites of the anticonvulsant remacemide. Epilepsy Res. 12: 9-20.
24. PORTER, R. H. P., AND J. T. GREENAMYRE. 1995. Regional variations in the pharmacology of NMDA receptor channel blockers: Implications for therapeutic potential. J. Neurochem. 64: 614-623.
25. RABEY, J. M., P. NISSIPEANU, AND A. D. KORCZYN. 1992. Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J. Neural Transm. [Parkinson's Dis. Dementia Sect.] 4: 277-282.
26. REGEHR, W. G., AND D. W. TANK. 1990. Postsynaptic NMDA receptor-mediated calcium accumulation in hippocampal CA1 pyramidal cell dendrites. Nature 345: 807-810.
27. ROGAWSKI, M. A. 1993. Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14: 325-331.
28. ROTHMAN, S. M. 1992. Excitotoxins: Possible mechanisms of action. Ann. NY Acad. Sci. 648: 132-139.
29. TANABE, S., M. MASU, T. ISHII, R. SHIGEMOTO, AND S. NAKANISHI. 1992. A family of metabotropic glutamate receptors. Neuron 8: 169-172.
30. WATKINS, J. C., AND R. H. EVANS. 1981. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21: 165-204.
31. 2- antagonise NMDA and GABA responses of hippocampal neurons. Nature 328: 640-643.
32. WILLIAMS, K., C. ROMANO, M. A. DICHTER, AND P. B. MOLINOFF. 1991. Modulation of the NMDAreceptor by polyamines. Life Sci. 48: 469-498.